ABSTRACT: The pathomechanism of the ligamentum flavum (LF) hypertrophy in diabetic patients with lumbar spinal canal stenosis (LSCS) remains unclear. A cross-sectional study was undertaken to investigate the mechanism of LF hypertrophy in these patients. Twenty-four diabetic and 20 normoglycemic patients with LSCS were enrolled in the study. The structure of the LF in the study subjects was evaluated using histological and immunohistochemical methods, and the levels of sorbitol, pro-inflammatory cytokines, and the fibrogenic factor, TGF-b1, in the LF were analyzed. In vitro experiments were performed using NIH3T3 fibroblasts to evaluate the effect of high-glucose conditions and an aldose reductase inhibitor on the cellular production of sorbitol, pro-inflammatory factors, and TGF-b1. We found that the LF of diabetic patients exhibited significantly higher levels of sorbitol and pro-inflammatory cytokines, TGF-b1 and of CD68-positive staining than that of the normoglycemic subjects. The diabetic LF was significantly thicker than that of the controls, and showed evidence of degeneration. The high glucose-cultured fibroblasts exhibited significantly higher levels of sorbitol, pro-inflammatory factors, and TGF-b1 compared to the low glucose-cultured cells, and these levels were dose-dependently reduced by treatment with the aldose reductase inhibitor. Taken together, our data suggests that increased sorbitol levels in the LF of diabetic patients results in increased production of pro-inflammatory and fibrogenic factor, which contribute to LF hypertrophy, and could increase the susceptibility of diabetic patients to LSCS. Furthermore, aldose reductase inhibition effectively reduced the levels of sorbitol and sorbitol-induced pro-inflammatory factor expression in high glucose-cultured fibroblasts. 1 LSCS is also associated with ligamentum flavum (LF) hypertrophy, disc degeneration, the mechanical instability, facet degeneration and hypertrophy.
Lumbar spinal canal stenosis(LSCS) is a common disorder in older individuals and causes radiculopathy or neurogenic claudication. 1 LSCS is also associated with ligamentum flavum (LF) hypertrophy, disc degeneration, the mechanical instability, facet degeneration and hypertrophy. 2, 3 LF hypertrophy, in particular, contributes to the pathology of LSCS. 4, 5 Fibrosis, the primary cause of LF hypertrophy, is induced by the accumulation of proinflammatory factors, including IL-6, TNF-a, PGE 2 , NO, MMP13, TGF-b, PDGF-BB, and bFGF. [6] [7] [8] [9] [10] [11] [12] Diabetes mellitus (DM) is a chronic metabolic disease characterized by hyperglycemia, which causes morbid and mortal complications, such as retinopathy, neuropathy, nephropathy, and microvascular damage. 13 The polyol/sorbitol pathway plays an intrinsic role in the development of these DM-associated disorders. 14 Aldose reductase (AR) initiates the polyol/ sorbitol pathway, which converts the excess glucose to sorbitol, leading to an increased accumulation of sorbitol in the tissues, 13 and to the production of an osmotic gradient that allows the influx of excess sodium and water. The increased polyol/sorbitol pathway activity is also an important source of diabetesinduced oxidative stress, 15 which causes cell damage and induces inflammation-associated hypertrophy. Furthermore, DM occurs with a high incidence of 13.6% in LSCS patients (compared with 5.9% in the general population), 16 which seems that DM patients are more susceptible to LSCS. However, the reason of susceptibility remains unclear, in particular, the pathomechanism of LF hypertrophy in DM patients with LSCS remains unexplored.
We hypothesized that DM causes increased sorbitol levels in the LF, which may induce an inflammatory response, followed by LF hypertrophy. The purpose of this study was to compare sorbitol levels in the LF of LSCS patients with DM to those of LSCS patients without DM. In addition, we treated high glucosecultured fibroblasts with an aldose reductase (AR) inhibitor and evaluated its effects on the accumulation of sorbitol, sorbitol-induced inflammatory factors, and TGFb1, a crucial proliferative factor that promotes fibrosis.
MATERIALS AND METHODS
This study was approved by the Institutional Review Board of Keio University School of Medicine, and all of the patients agreed to participate in the study. LF tissue samples were obtained from 44 LSCS patients undergoing decompressive laminectomy for severe neurogenic claudication. Twenty-four of the patients were DM positive (þ), and 20 were DM negative (À). The mean ages were 68.9 AE 10.8 years in the DM (þ) group and 75.1 AE 8.9 years in the DM (À) group (p ¼ 0.258) ( Table 1) . No significant differences were observed between the DM (þ) and (À) groups in body mass index (BMI), gender distribution, or level of surgery (Table 1) .
Quantitative Analysis of Sorbitol Levels in the Study Subjects During surgery, the LF was removed en bloc, and then the attached epidural fat and bone fragments were removed from the samples. The samples were immediately stored at À80˚C for subsequent analysis. A 10-mg aliquot of each sample was homogenized and suspended in 1.0 ml ice-cold 8% perchloric acid (PCA). After centrifugation (5,500g, 4˚C, 10 min), the supernatant was discarded and the cells were resuspended in 3.0 ml ice-cold 8% PCA. The cells were then centrifuged (5,500g, 4˚C, 10 min), the PCA-insoluble precipitate was discarded, and the supernatant was saved and incubated with 2 M K 2 CO 3 . After another centrifugation (5,500g, 4˚C, 10 min), the supernatant was saved for analysis using the D-Sorbitol/Xylitol Assay Kit (Megazyme International, Ireland). The absorbance of each sample at 492 nm was measured with a plate reader. The experiment was performed three times, and the results were averaged.
Measurement of LF Thickness
The thickness of the LF was measured using the axial images of the preoperative computed tomography (CT) (GE Healthcare, Fairfield, CT). The thickness of both sides of the LF was measured following the method described by Fukuyama et al. 17 : All scans were performed in the supine position, routinely at disk level with adjusted slice angle. On the axial scan through the facet joint, the thickness of the right and left parts of the LF were measured using a sliding capiler, averaged, revised with magnification.
Image-analysis software was used that provided digital measurements with a precision of 0.1 mm (Centricity Enterprise Web 3.0, GE Healthcare). The measurements were performed three times, and the results were averaged.
Hematoxylin and Eosin (HE) and Masson's Trichrome Staining
Collected LF specimens were immediately fixed in 4% neutral formalin and embedded in paraffin. The embedded tissues were then sliced into 5-mm-thick sections for HE and Masson's trichrome staining. HE staining was used to analyze the degradation of the elastic fibers, and Masson's trichrome staining was used to evaluate LF fibrosis.
Immunohistochemical (IHC) Analysis of the LF
The LF samples were fixed in 4% neutral formalin, decalcified in 20% ethylenediaminetetraacetic acid (EDTA) for 4 weeks, and then embedded in paraffin and sectioned. The samples were mounted on slides and then deparaffinized and rehydrated using Tris-buffered saline. To retrieve antigens, the slides were heated for 5 min in10 mM citrate buffer. After blocking in 5% goat serum, the slides were incubated for 2 h with an anti-CD68 antibody (Santa Cruz Biotechnology, Santa Cruz) diluted 1:200 in Tris-buffered saline. A control sample was incubated for the same length of time in the absence of antibody. The slides were then incubated with goat-anti-rabbit immunoglobulin (1:400; Santa Cruz Biotechnology) for 1 h at room temperature. The chromogen, diaminobenzidine, was used to visualize the staining.
Cell Proliferation Analysis NIH3T3 cells were seeded in a 96-well plate at 8 Â 10 4 cells/well and incubated at 5% CO 2 and 37˚C in a humidified chamber. The cells were divided into two groups that were incubated either under normal glucose (5 mM) or high glucose (25 mM) 18 conditions, and each group contained five replicate wells. The cell proliferation activity of each group was measured at 0, 24, 48, and 72 h after cell adhesion using a Cell Counting Kit-8 (Sigma). The CCK-8 solution was added at 10 ml/well, and the cells were incubated at 37˚C for 2 h. The samples' absorbance at 450 nm was determined in a plate reader. The experiment was performed three times.
Cell Cycle Analysis
Cell cycle analysis was performed using flow cytometry (BD). The cells were incubated in serum-free medium for 24 h followed by incubation in complete medium for 48 h, and then collected and resuspended in 100 ml of phosphate buffered saline (PBS). Precooled anhydrous ethanol was slowly added to dilute the suspension to 400 ml. After removing the ethanol by centrifugation, the cells were resuspended in 100 ml of PBS, and iodinated propidium was added to a final concentration of 50 mg/ml, followed by the addition of RNase A to a final concentration of 100 mg/ml. The cells were then incubated at 4˚C for 30 min prior to cell cycle analysis. The experiment was performed three times.
NIH3T3 Cell Treatment With Epalrestat, an AR Inhibitor NIH3T3 cells were seeded onto 12-well plates at 8 Â 10 4 cells/ well and maintained in DMEM (Sigma) supplemented with 10% fetal calf serum, streptomycin (100 mg/ml), and penicillin (100 U/ml). The cells were incubated in a humidified atmosphere containing 5% CO 2 at 37˚C. The cells were divided into four groups that were cultured under the following conditions: (i) normal glucose (5 mM); (ii) high glucose (25 mM); (iii) high glucose (25 mM) plus 0.1 mM epalrestat; or (iv) high glucose (25 mM) plus 1.0 mM epalrestat. The cells were harvested after 48 h of culture and analyzed using the quantitative sorbitol assay kit as described above, or subjected to quantitative PCR or Western blotting, to examine the pro-inflammatory cytokine production.
Quantitative PCR Total RNA was extracted from LF tissue and NIH3T3 cells by using TRIzol (Invitrogen Corporation), and the concentration and quality were determined by using an ND-1000 spectrophotometer (NanoDrop). The total cellular mRNA was reverse transcribed using the EasyScript First-Strand cDNA Western Blotting Cellular proteins were extracted with radio-immunoprecipitation (RIPA) lysis buffer. Total protein concentrations were determined by using an ND-1000 spectrophotometer (NanoDrop). Ten micrograms of total protein was diluted with 5Â sample buffer (0.06 M Tris, pH 6.8, 2% sodium dodecyl sulfate, 0.3 M b-mercaptoethanol, 0.1% bromophenol blue, 10% glycerol), and the samples were incubated at 95˚C for 5 min. The samples were then subjected to 10% polyacrylamide gel electrophoresis (80 V, 1 h) in Tris-glycine-sodium dodecyl sulfate running buffer. The separated proteins were then transferred to an immunoblot membrane in transfer buffer (25 mM Tris, pH 8.3, 20% methanol) for 2 h. The membrane was then incubated in TBST (100 mM Tris, pH 7.5,0.9% NaCl, 0.5% Tween 20) . After blocking with 5% nonfat dry milk, the membrane was incubated with a primary antibody (1:200, BosterImmunoleader, Pleasanton, CA) at 4˚C overnight, and then incubated with goat-antirabbit antibody conjugated with horseradish peroxidase (1:2,000, Dako, Denmark). The membranes were then washed three times in the TBST and exposed to film.
Statistical Analysis
All values are reported as mean AE standard deviation. Student's t-test was used for comparisons between two groups, and ANOVA was used for comparing larger numbers of groups. The IBM SPSS Statistics 19 software package (IBM, Tokyo, Japan) was used for statistical analyses. A p-value of less than 0.05 was considered to be statistically significant.
RESULTS

Sorbitol Levels in the LF of Diabetic and Nondiabetic Patients With LSCS
The sorbitol levels in the LF from the LSCS DM (þ) and DM (À) patients were 1.68 (AE 0.56) mg/L and 0.42 (AE0.69) mg/L, respectively (Fig. 1) . Thus, the average sorbitol level in the LF was four times higher in DM (þ) patients than in DM (À) patients. The difference between the two groups was found to be statistically significant (p < 0.01).
LF Thickness in the Study Subjects
The mean thickness of the LF, determined from measurements of the preoperational CT images, was 5.60 (AE0.80) mm in the DM (þ) group and 3.92 (AE0.58) mm in the DM (À) group (Fig. 2) . The difference in LF thickness between the two groups was found to be statistically significant (p < 0.01).
Histological Findings in the LF of DM (þ) and DM (À) Patients HE staining showed no difference in cellularity between the DM (þ) LF and DM (À) LF (data not shown); however, the fibers in the DM (þ) LF were found to be partially degraded. In the DM (À) LF, coiled and wave-like elastic fibers were abundant and accompanied by regularly arranged collagenous fibers (Fig. 3A) . In contrast, in the DM (þ) LF, there were fewer elastic fibers, and those that were observed were disrupted and partially degraded (Fig. 3B) . In Table 2 . Primer Sequences addition, the collagenous fibers in the DM (þ) LF were irregularly arranged and exhibited a hypertrophic phenotype.
Masson trichrome staining showed clear evidence of elastic fiber degradation and hyperplasia of the collagenous fibers in the LF of DM (þ) patients. Both of these features were present to a much lesser extent in the LF of DM (À) patients (Fig. 3C and D) .
CD68 IHC Staining of the LF From DM (þ) and DM (À) Patients IHC analysis showed that the LF from DM (þ) patients exhibited stronger CD68 staining compared to that from DM (À) patients (Fig. 3E and F) . The strong CD68 staining in the DM (þ) LF indicated an increase in macrophage infiltration, indicative of an inflammatory response. Fig. 4A and B) . In addition, our analysis showed that a higher proportion of the high glucose-cultured cells were in the S phase of the cell cycle, compared with the normal glucose-cultured cells (Fig. 4C ).
Cell Proliferation and Cell Cycle Analysis in NIH3T3 Cells
NIH3T3 cells cultured under high glucose conditions exhibited significantly higher levels of proliferation than cells cultured under normal conditions (
Sorbitol Levels in NIH 3T3 Cells
High glucose-cultured cells exhibited significantly higher levels of sorbitol (1.68 AE 0.37) than normal (Fig. 5) . Furthermore, treatment of the high glucose cultures with 0.1 and 1.0 mM epalrestat significantly suppressed the increased sorbitol levels to 1.12 AE0.29 mg/L (p < 0.01) and 0.84 AE0.11 mg/L (p < 0.01), respectively. These findings showed that the sorbitol levels of high glucose-cultured cells were $2-fold higher than that of normal glucose-cultured cells and that the increased production of sorbitol was effectively suppressed by AR inhibition (Fig. 5) .
Inflammatory Cytokine and Pro-Fibrotic Factor Expression in the LF of DM (þ) and DM (À) Patients and High Glucose-Cultured NIH3T3 Cells
Real-time PCR analysis showed that the expression of mRNAs encoding the pro-inflammatory cytokines (IL-1a, IL-1b, IL-6, and TNF-a) and pro-fibrotic factors (TGF-b1 and COL-1) was significantly higher in the LF of DM (þ) patients than in that of DM (À) patients (Fig. 6 ). In addition, we found that these mRNAs were also significantly upregulated in the high glucosecultured cells compared with the control cells, and that the increased mRNA levels were dose-dependently downregulated after treatment with epalrestat (Fig. 7) .
The above findings were further supported by Western blotting analysis of NIH3T3 cells cultured under high and normal glucose conditions. The IL-6, TNF-a, TGF-b1, and COL-1 protein expressions were significantly upregulated in the high glucose-cultured cells compared with normal glucose-cultured cells (Fig. 8) . Furthermore, the elevated expression of these proteins was significantly and dose-dependently decreased by epalrestat treatment.
DISCUSSION
In the present study, we found that the sorbitol levels in the LF of LSCS DM (þ) patients were significantly higher than those in the LF of LSCS DM (À) patients. In addition, the mean thickness of the LF in the DM (þ) group was significantly greater than that in the DM (À) group. We also found that a number of mRNAs encoding pro-inflammatory cytokines and the profibrotic factor, TGF-b1, were significantly upregulated in the LF of the DM (þ) group. Furthermore, the same factors were upregulated in high glucose-cultured NIH3T3 fibroblasts, and downregulated following aldose reductase inhibition, which reduces sorbitol accumulation. Thus, our results suggest that the increased levels of sorbitol in diabetic patients induce inflammation and fibrosis in the LF, resulting in LF hypertrophy and the progression of LSCS.
Previous studies suggested a link between LF hypertrophy and inflammation-induced fibrosis. [6] [7] [8] [9] [10] [11] [12] Park et al. reported that proinflammatory mediators, including IL-6, TNF-a, PGE 2 , and NO, can induce fibrosis and ossification of human LF cells, 6 while Cui et al. found that high MMP13 expression contributes to LF hypertrophy. 8 Zhang et al. reported that the PDGF-BB levels are proportional to the severity of LF fibrosis in LSCS, 9 and others indicated that TGF-b and bFGF play crucial roles in LF hypertrophy. [10] [11] [12] However, most of the previous studies investigated the roles of inflammatory cytokines in LF hypertrophy in normoglycemic LSCS patients. In this study, we investigated the pathogenesis contributing to LF hypertrophy in DM (þ) LSCS patients.
Hyperglycemia triggers the activity of AR, which is a primary enzyme in the polyol/sorbitol pathway that catalyzes the conversion of glucose to sorbitol, resulting in the accumulation of sorbitol in tissues. 19 ARmediated polyol/sorbitol pathway activity leads to the upregulation and/or activation of various cytokines and transcription factors. One of the affected cytokines is TGF-b, which has been shown to play a pivotal role in enhancing extracellular matrix synthesis. The enhanced production of collagen, in particular, is associated with the progression of fibrosis. 20, 21 The results of the present study showed that sorbitol levels were higher in the LF tissue from DM (þ) patients than in that from DM (À) patients, and that the LF in the DM (þ) patients was significantly thicker than that in the DM (À) patients. These findings suggest that increased levels of hyperglycemia-induced sorbitol may contribute to LF hypertrophy in DM (þ) LSCS patients.
We also found that LF hypertrophy was associated with an excessive generation of collagenous fibers. Masson trichrome staining showed that the LF of DM (þ) patients consisted primarily of collagenous fibers, while the elastic fibers were substantially degraded. The LF normally contains elastic fibers that are arranged in parallel arrays. During the hypertrophic process, elastic fibers become increasingly fragmented, Figure 6 . Quantitative analysis of mRNAs encoding pro-inflammatory and pro-fibrotic factors in the LF of the study subjects. Real-time PCR analysis showed that the average levels of mRNAs encoding IL-6, IL-1a, IL-1B, TNF-a, COL-1, and TGF-b1 were significantly higher in the LF of the DM (þ) LSCS group than in that of the DM (À) LSCS group. Average values with standard deviation are shown.
Ã p < 0.05, ÃÃ p < 0.01, ÃÃÃ p < 0.001.
SORBITOL IN DIABETIC LIGAMENTUMFLAVUM disordered, and finally degraded, and the gradual loss of elastic fibers is replaced by thickened and disordered collagen fibers. This type of tissue conversion in the LF of LSCS patients has been well-documented. However, our findings showed that this conversion is far more severe in the LF of DM (þ) LSCS patients than in that of DM (À) patients. Our in vitro studies showed that NIH3T3 mouse fibroblasts cultured under high glucose conditions exhibited higher proliferative rates and a larger proportion of cells in S phase than control cells cultured under normal glucose conditions. However, we found no significant difference in the number of LF fibroblasts in DM (þ) and DM (À) patients with LSCS. Theoretically, the increased sorbitol accumulation in the LF cells of DM patients could result in higher osmotic pressure and increased cell expansion, which could contribute to hypertrophy. However, this theoretical phenomenon is not observable either histologically or cytologically. Another possibility is that LF hypertrophy is due to inflammation-induced fibrotic changes rather than the proliferation and expansion of fibroblasts/fibrocytes. The increased number of perivascular CD68 þ macrophages 22 in the LF of DM (þ) patients suggests the presence of inflammation in the hypertrophied ligament and is consistent with our theory. In addition, our findings are in agreement with those of L€ ohr et al., who reported that macrophages are involved in LF hypertrophy. 12 As described in the Introduction, inflammation plays a key role in degenerative LF fibrotic hypertrophy. Our findings suggest that in DM patients with LSCS, sorbitol accumulation maybe the primary underlying mechanism of the inflammation that leads to LF hypertrophy. Hyperglycemia-driven polyol/sorbitol pathway activation is thought to contribute to oxidative-stress-mediated tissue damage, by increasing the generation of reactive oxygen species (ROS). 23 AR catalyzes the nicotinamide adenosine dinucleotide phosphate (NADPH)-dependent reduction of glucose to sorbitol. Oxidative-stress-mediated tissue damage induces the expression of proinflammatory cytokines and fibrogenic factors such as TGF-b. 21, 24 To investigate the involvement of AR in the increased sorbitol levels in the LF of DM (þ) patients, we examined the effect of the AR inhibitor, epalrestat, on sorbitol levels in NIH3T3 fibroblasts cultured under high glucose conditions. As expected, we found that the sorbitol levels were significantly upregulated in fibroblasts cultured under high glucose conditions, and that the sorbitol levels were dose-dependently reduced by epalrestat treatment. Western blotting and quantitative PCR further revealed that the expression of a set of proinflammatory cytokines (IL-6, IL-1a, IL-1b, and TNF-a), and the fibrogenic factors TGF-b1 and collagen I were significantly upregulated in response to high glucose conditions, and that the upregulated mRNAs and proteins were substantially downregulated by epalrestat treatment. Thus, AR inhibition may play a therapeutic role in DM patients with LSCS.
There are limitations in this study. Firstly, high glucose condition upregulates TGF-b1 which can facilitate the transcript of collagen I by ERK/MAPK or Smad signaling pathways. 25 Studies show the ERK and Smad pathways may be of cross-talk and both ERK and Smad pathways seem to play a role in the development of fibrosis accelerated by high blood glucose. 26, 27 Here, we have still not known the exact pathway of TGF-b1 inducing collagen I in DM patients with LF hypertrophy. It is worthy to investigate the signaling pathway involved in the development of fibrosis in this cohort in the future. Secondly, NIH3T3 cell is a cell line of primary mouse embryonic dermal fibroblast cells. Compared with adult ligament fibroblast, NIH3T3 may have different proliferative ability and cells cycle when responses to high glucose condition.
In conclusion, higher levels of sorbitol were found in the LF from DM (þ) LSCS patients than in the LF from DM (À) LSCS patients, and the LF was significantly thicker in DM (þ) than in DM (À) patients. Our findings suggest that hyperglycemiadriven sorbitol pathway activation contributes to inflammation and LF fibrotic hypertrophy, and this pathomechanism may increase the susceptibility of DM patients to LSCS.
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